Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-25 @ 9:27 PM
NCT ID:
NCT04034056
Pre Assignment Details:
This was a prospective and retrospective data collection study. Participants were observed for safety and efficacy of obinutuzumab during the 6-month induction treatment with obinutuzumab and chemotherapy, and 24-month maintenance treatment with obinutuzumab monotherapy followed by 1 year of follow up.
Recruitment Details:
A total of 299 participants with untreated advanced follicular lymphoma (FL) took part in the study at 50 investigative sites in Italy from 02 September 2019 to 22 April 2024.
Study:
NCT04034056
Study Brief:
Results Section:
NCT04034056